The immune cells were at a 7 times higher ratio in lung samples from men than women, and may explain sex differences between ...

PH is defined as high lung blood pressure with various underlying causes. In comparison, PAH is a rare and gradually worsening condition in which the blood pressure in the pulmonary arteries becomes ...

The PAH treatment market is expected to grow from USD 5,811.5 million in 2023 to USD 7,224.4 million by 2033, at a CAGR of ...

fDivision of Pulmonary and Critical Care Medicine and The Mary M Parkes Center, University of Rochester Medical Center, Rochester, NY, USA gDepartment of Cardiovascular Diseases, Mayo Clinic College ...

Researchers from Morphic Therapeutic Inc. and affiliated organizations published data from a study that aimed to assess the potential of using arginylglycylaspartic acid (RGD) integrins for the ...

Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more ...

Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development --- --- John Adams, PhD Appointed Chief Scientific Off ...

Right ventricular–pulmonary artery coupling (RV-PAC) describes the energy transfer within the whole cardiopulmonary unit. Thus, it can identify the earliest signs of decompensation even before ...